Gene therapy preparations manufacturing · New Jersey

Minaris Regenerative Medicine

Allendale, NJ · ~264 workers · 5 years of OSHA Injury Tracking Application data.

A
Excellent Safety Record
0.4
Avg TCR
3.3
Industry avg
0
Fatalities
Subscribe to safety-record updates (RSS)

The verdict

Minaris Regenerative Medicine runs at 13% of its industry's injury rate - far safer than the typical Gene therapy preparations manufacturing workplace, earning a grade A.

Minaris Regenerative Medicine: 0.4 TCR = 13% of Gene therapy preparations manufacturing BLS 3.3 · 5y Form 300A (see methodology below)

Minaris Regenerative Medicine safety composite

Minaris Regenerative Medicine scores strongest on dart rate (safer than 83% of same-industry peers) and weakest on fatalities (safer than 50%), blended into one 0-100 breakdown against same-industry peers. A missing measure drops out and redistributes its weight rather than deflating the score. This is a per-dimension breakdown, distinct from the single letter grade above it (which weights TCR alone against the BLS industry benchmark).

C

74/100

Percentile-weighted across 3 of 3 measures

Total Case Rate (TCR)
B 0.44 per 100 workers

Safer than 81% of industry peers

DART rate
B 0 per 100 workers

Safer than 83% of industry peers

Fatalities
D 0

Safer than 50% of industry peers

Benchmarked live against every credibly-rated employer in the same NAICS industry code in the current OSHA extract (a segment must have at least 8 rated peers to benchmark). Not a legal or compliance determination; PlainSafetyScore's own weighting (TCR 40%, DART 35%, fatalities 25%).

Minaris Regenerative Medicine held a steady TCR band

Minaris Regenerative Medicine's TCR held near 0.0 from 0.0 in 2020 to 0.0 in 2024. Peak filing year was 2023 at 1.1 TCR. In 2024, DART was 0× this establishment's average TCR (severity share of cases).

2020=0.0 · 2021=0.4 · 2022=0.7 · 2023=1.1 · 2024=0.0

OSHA ITA Form 300A scorecard

Establishment book 325414 · Allendale, NJ AT/BELOW-IND · MID

Grade A · TCR 0.4 · 13% of ind

  • DART 0.0 DART
  • RANK #2/9
  • PHOTO Biogen - US Field
  • BOOK 5y book
  • INJ 5 inj
  • SIZE ~264 FTE

Nearest TCR peer: Biogen - US Field (0.0 TCR gap)

Read with this employer → · Industry book → · New Jersey employers → · Look up another →

Minaris Regenerative Medicine in the TCR neighbourhood

Average Total Case Rate among this establishment and nearest same-industry peers

TCR

What this shows Minaris Regenerative Medicine averages 0.4 TCR (13% of the Gene therapy preparations manufacturing BLS benchmark).

Source U.S. Department of Labor, OSHA Injury Tracking Application (Form 300A) As of 2026-08-25

Minaris Regenerative Medicine TCR series: 2020=0 · 2021=0.4 · 2022=0.7 · 2023=1.1 · 2024=0 · BLS 3.3

Where Minaris Regenerative Medicine falls in its industry

234 Gene therapy preparations manu establishments

Safer than 81% of graded establishments in this industry, whose median TCR is 1.2.

More dangerous than peersSafer than peers

Narrower to New Jersey alone (the establishments it most directly competes with for workers and contracts): ranked #2 safest of 9 Gene therapy preparations manu employers in New Jersey.

Minaris Regenerative Medicine (264 employees, TCR 0.4) among 29 same-industry peers, split at the industry median of 198 employees and a TCR of 1.2 2×2 strategic matrix plotting 30 entities by Average employees (X) and Total Case Rate (Y), with a crosshair dividing the plot into four quadrants. Larger & higher-riskSmaller & higher-riskLarger & saferSmaller & safer than peers 05001,0001,5002,000 0246 Average employees Total Case Rate Minaris Regenerative Medicine
Minaris Regenerative Medicine (264 employees, TCR 0.4) among 29 same-industry peers, split at the industry median of 198 employees and a TCR of 1.2

Minaris Regenerative Medicine has more employees than the Gene therapy preparations manufacturing median and a lower injury rate than the industry's median TCR of 1.2. Workforce size and injury rate do not always move together within the same industry -- some of its smaller peers run higher rates than its larger ones, and vice versa.

Year-by-Year Safety Data

Year TCR DART Injuries Illnesses Fatalities
2024 0.0 0.0 0 0 0
2023 1.1 0.4 3 0 0
2022 0.7 0.7 1 1 0
2021 0.4 0.0 1 0 0
2020 0.0 0.0 0 0 0

OSHA ITA peer cross-reference

Establishment peer ledger

325414 · NJ · Allendale

234 Gene therapy preparations manufacturing employers nationwide with a credible TCR · 11,201 rated employers in New Jersey with headcount on file · 17 employers in Allendale, NJ · 4 cross-state NAT-TCR peers · 4 cross-state NAT-SIZE peers. Closest matches by relationship code are listed below.

Rel Establishment Metric
NAICS-TCR Biogen - US Field 0.4 TCR
NAICS-TCR bluebird bio Research Triangle 0.4 TCR
NAICS-TCR Regeneron - Industrial Operations and Product Supply (IOPS) 0.5 TCR
NAICS-TCR Organon Teknika Facility 0.5 TCR
STATE-SIZE Weeks Marine Construction 264 FTE
STATE-SIZE TFH Publications Inc. - Neptune City 264 FTE
STATE-SIZE TFH Publications, Inc. - Jamesburg 264 FTE
STATE-SIZE AIR CRUISERS COMPANY, INC 264 FTE
CITY-NEAR Stryker Spine 328 FTE
CITY-NEAR Hitachi Chemical Advanced Therapeutics Solutions 168 FTE
CITY-NEAR CAI NJ 159 FTE
CITY-NEAR Allendale 157 FTE
NAT-TCR Southeastern Plumbing and Heating, Inc. 0.4 TCR
NAT-TCR Hampton Inn & Suites Columbia at the University of Missouri 0.4 TCR
NAT-TCR Frank Rewold and Son, Inc. - Main Branch 0.4 TCR
NAT-TCR MMR Constructors, Inc. - Mobile Operations 0.4 TCR
NAT-SIZE Sulzer Pump Services (US) Inc. 264 FTE
NAT-SIZE Cyprexx Services 525 264 FTE
NAT-SIZE Giffin Inc 264 FTE
NAT-SIZE ShopRite of Bethlehem 264 FTE

Rel codes: NAICS-TCR · STATE-SIZE · CITY-NEAR · NAT-TCR/NAT-SIZE cross-state. Read with this employer →

Data Source: OSHA Injury Tracking Application (ITA), mandatory establishment-level injury/illness reports. Grades compare employer Total Case Rate (TCR) to BLS IIF industry benchmarks. Data covers years reported by this establishment: 2024, 2023, 2022, 2021, 2020. This is publicly available government data - not a legal determination of workplace conditions.

Read our methodology - how this data is sourced, computed, and verified.

Data sourced from official public datasets. See our methodology for details.